Depressive disorders: epidemiology, burden of disease, medical and social characteristics of the patients

Full Text:   Subscribers Only

Suggested citation:

Medvedev AD, Pavlichenko AV, Trushchelev SA, et al. [Depressive disorders: epidemiology, burden of disease, medical and social characteristics of the patients]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2023;(6):76-86. Russian

Abstract

In this scientific review of a narrative type with the aim of summarizing the results of the analysis of grouped publications on the epidemiology and burden of depressive disorders, as well as the medical and social characteristics of people with depressive disorders, using stable phrases and keywords in relevant bibliographic systems and databases (Scientific Electronic Library elibrary.ru, Cyberleninka, PubMed) a search for scientific publications was conducted. A total of 256 articles were found, 68 sources were used for citation. There are signs of a significant increase in the incidence of depressive disorders: over the decade (2007–2017), the number of new cases increased by 17.8%, and during the years of the COVID-19 pandemic, this figure increased by another 21.6%. Scientific work on the epidemiology of depressive disorders in Russia is required, as well as additional measures to improve the diagnosis and improve the effectiveness of treatment of people with depressive disorders, especially in the primary medical network.

Keywords depression; depressive disorders; epidemiology; burden of disease; comorbidity

References

1. Kornetov NA. Semiotics, diagnostics and therapy tactics of depressive disorders in clinical medicine. Bulletin of Siberian Medicine. 2014;13(3):5–24. (In Russ.) DOI: .org/10.20538/1682-0363-2014-3-5-24 2. World Health Organisation. The World Health Report, 1999. Geneva: WHO, 1999. 121 p. 3. Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA. 2003;289(23):3145–51. DOI: https://doi.org/10.1001/jama.289.23.3145 4. Cleare A, Pariante CM, Young AH, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015;29(5):459–525. DOI: https://doi.org/10.1177/0269881115581093 5. Kessler RC. The costs of depression. Psychiatr Clin North Am. 2012;35(1):1–14. DOI: https://doi.org/10.1016/j.psc.2011.11.005 6. Lam R. Depression. Oxford University Press; 2018, 160 p. 7. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858. DOI: https://doi.org/10.1016/S0140-6736(18)32279-7 8. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700–12. DOI: https://doi.org/10.1016/S0140-6736(21)02143-7 9. Institute of Health Metrics and Evaluation. Global Health Data Exchange (GHDx). URL: https://vizhub.healthdata.org/gbd-results/ (accessed on: 04.03.2023). 10. Chen CM, Slater M.E, Castle I-JP, Grant BF. Alcohol Use and Alcohol Use Disorders in the United States: Main Findings from the 2012–2013 National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). U.S. Alcohol Epidemiologic Data Reference Manual, ed. Vol. 10. Publication No 16-AA-8020. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism, 2016. 120 p. 11. Jacobi F, Nübel J, Müllender S, et al. Veränderungenund Variationen der Häufigkei tpsychischer Störungen in Deutschland – Krankenk assenstatistiken und epidemiologische Befunde. Blickpunkt Psyche – Gesundheit in Regionen / K Kliner, D Rennert, M Richter, editors. MWV Medizinisch Wissenschaftliche Verlagsgesellschaft; 2015. 103 р. (In German) 12. Nübel J, Müllender S, Hapke U, Jacobi F. Epidemie der Depression? Prävalenzentwicklung und Inanspruchnahme von Hilfs- und Versorgungsangeboten. Nervenarzt. 2019;90(11):1177–86. (In German?) DOI: https://doi.org/10.1007/s00115-019-0681-y 13. Léon C, Chan Chee C, du Roscoät E; le groupe Baromètre santé 2017. La dépression en France chez les 18–75 ans: résultats du baromètre s anté 2017. BEH. 2018;(32–33):637–44. (In French) 14. Guardia D, Salleron J, Roelandt JL, et al. Prevalence of psychiatric and substance use disorders among three generations of migrants: Results from French population cohort. Encephale. 2017;43(5):435–43. DOI: https://doi.org/10.1016/j.encep.2016.06.008 15. Sukiasyan SG, Margaryan SP, Manasyan NG, et al. [Epidemiology of depression: pronounced burden or problems of diagnosis?]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2010;(2):22–7. (In Russ.) 16. Shilova OV, Hodzhaev AV, Kaminskaya YM, et al. Rasprostranennost' depressivnyh rasstrojstv i kachestvo zhizni, svyazannoe so zdorov'em, u vzroslogo naseleniya Respubliki Belarus' (po dannym kliniko-epidemiologicheskogo issledovaniya 2020–2022 godov. Voprosy organizacii i informatizacii zdravoohranenija. 2022;(4):57–65. (In Russ.) 17. Aleksandrovskij YA, et al. Novye organizacionnye formy pomoshchi bol'nym s pogranichnymi nervno-psihicheskimi rasstrojstvami. 5-j Vseros. s"ezd nevropatologov i psihiatrov. Moscow; 1985. р. 58–60. (In Russ.) 18. Vorob'eva OV. Klinicheskie osobennosti depressii v obshchemeditsinskoy praktike (po rezul'tatam programmy “KOMPAS”). Consilium Medicum. 2004;6(2);154–8. (In Russ.) 19. Shal'nova SA, Evstifeeva ES, Deev AD, et al. Rasprostranennost' trevogi i depressii v razlichnyh regionah Rossijskoj Federacii i ee associacii s social'no-demograficheskimi faktorami (po dannym issledovaniya ESSE-RF). Terapevticheskii arkhiv. 2014;86(12):53–60. (In Russ.) 20. Paykel ES, Brugha T, Fryers T. Masshtaby i bremia depressivnykh rasstroistv v Evrope (rasshirennyi referat obzora). Psikhiatriia i psikhoformakoterapiia. 2006;(8):3. (In Russ.) 21. Smulevich AB. Depressii v klinicheskoj praktike vrachej obshchemedicinskih special'nostej. RMZH. 2011;19(9):597–600. (In Russ.) 22. Ivanov SV. [Depressive disorders in oncology (review)]. Zh Nevrol Psikhiatr Im SS Korsakova. 2012;112(11 2):104–9. (In Russ.) 23. Smulevich AB. Psihicheskie rasstrojstva v klinicheskoj praktike. Moscow: MEDpress-inform; 2011. 720 р. (In Russ.) 24. Lisitsyna TA, Zeltyn' AE, Vel'tishchev DJu, et al. [Cognitive impairment and anxiety-depressive disorders in patients with rheumatoid arthritis]. Zh Nevrol Psikhiatr Im SS Korsakova. 2012;112(11 2):96–103. (In Russ.) 25. Zinchuk MS, Kustov GV, Pashnin EV, et al. [Screening for anxiety and depressive disorders in epilepsy: current state of the problem]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2021;(3):87–97. (In Russ.) DOI: http://doi.org/10.47877/1560-957Х-2021-10309 26. Zinchuk MS, Pashnin EV, Kustov GV, et al. Affektivnye rasstrojstva u pacientov s epilepsiej: Metodicheskie rekomendacii. Moscow; 2019. 24 p. (In Russ.) 27. Neznanov NG, Kibitov AO, Rukavishnikov GV, et al. [The prognostic role of depression as a predictor of the manifestation of chronic somatic diseases]. Terapevticheskij arhiv. 2018;90(12):122–32. (In Russ.) 28. Sadana R. Measurement of variance in health state valuations in Phnom Penh, Cambodia. Summary measures of population health: concepts, ethics, measurement and applications. CJL Murray, JA Salomon, CD Mathers, AD Lopez, editors. Geneva: World Health Organization; 2002. p. 593–618. URL: https://apps.who.int/iris/bitstream/handle/10665/42439/9241545518.pdf (accessed on: 12.10.2023). 29. Health Care Cost, Quality, and Outcomes. ML Berger et al., editors. ISPOR; 2003. 264 р. 30. GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137–50. DOI: https://doi.org/10.1016/S2215-0366(21)00395-3 31. Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 (Global Burden of Disease and Injury Series). C Murray, A Lopez, editors. Cambridge, MA: Harvard School of Public Health; 1996. 356 p. 32. Kornetov NA. Depressivnye rasstrojstva (diagnostika, sistematika, semiotika, terapiya). Tomsk: Sib. izd. dom; 2003. 119 p. (In Russ.) 33. Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2129–43. DOI: https://doi.org/10.1016/S0140-6736(12)61680-8 34. Bocheeva EA, Hudina YuS, Polunina NV, et al. Affective pathology as a problem of medical and social expertise. Praktical Medicine. 2018;16(9):78–81. (In Russ.) DOI: https://doi.org/10.32000/2072-1757-2018-9-78-81 35. Malygin YaV, Tsygankov DB, Malygin VL, Shamov SA. [A multiple linear model of help-seeking behavior in patients with depressive and neurotic disorders]. Zh Nevrol Psikhiatr Im SS Korsakova. 2019;119(1 2):17–21. (In Russ.) DOI: https://doi.org/10.17116/jnevro20191191217 36. Ghio L, Gotelli S, Marcenaro M, et al. Duration of untreated illness and outcomes in unipolar depression: A systematic review and meta-analysis. J Affect Disord. 2014;152–154:45–51. DOI: https://doi.org/10.1016/j.jad.2013.10.002 37. Smulevich AB, Dubnickaya EB. Depressii v obshchemedicinskoj seti. Psihicheskie rasstrojstva v obshhemedicinskoj praktike. 2010;(1):4–13. (In Russ.) 38. Ovsepyan AA. Depressiya: ot lecheniya k profilaktike. Trudnyj pacient. 2015;13(3):46–9. (In Russ.) 39. Bekeneva LV. Depressivnye rasstrojstva v psihiatricheskoj praktike [Depressive disorders in psychiatric practice]. Vestnik Severo-Vostochnogo federal'nogo universiteta im. MK Ammosova. Seriya: Medicinskie nauki. 2017;4(9):17–22. (In Russ.) 40. Evstifeeva SE, Shal'nova SA, Makarova YuK, et al. Associiruetsya li uroven' trevogi i depressii v populyacii so smertnost'yu naseleniya? Po dannym issledovaniya ESSE-RF [Are the levels of anxiety and depression in a population associated with population mortality? According to the ESSE-RF study]. Kardiovaskulyarnaya terapiya i profilaktika. 2021;20(5):252–61. (In Russ.) 41. Kulikov AYu, Dedyurina YuM. Analiz stoimosti bolezni lecheniya pacientov, stradayushchih depressivnymi rasstrojstvami, v usloviyah zdravoohraneniya Rossijskoj Federacii [Analysis of the cost of illness of treatment of patients suffering from depressive disorders in the healthcare environment of the Russian Federation]. Farmakoekonomika. 2011;4(1):24–33. (In Russ.) 42. Erichev AN, Kotsyubinsky AP, Kuznetsova SL. [Depression as a biopsychosocial problem]. Zh Nevrol Psikhiatr Im SS Korsakova. 2021;121(5 2):7–11. (In Russ.) DOI: https://doi.org/10.17116/jnevro20211210527 43. Zakroeva AG, Lesniak OM. Biopsychosocial approach to patients care with main chronic noninfectionaldeseases at the primary stage of healthcare. Lechashij Vrach. 2014;(10):42–6. (In Russ.) 44. Tang J, Zhang T. Causes of the male-female ratio of depression based on the psychosocial factors. Front Psychol. 2022;13:052702. DOI: https://doi.org/10.3389/fpsyg.2022.1052702 45. Semke VYa, Polozhij BS, Krasik ED, et al. Epidemiologiya, klinika i profilaktika pogranichnyh sostoyanij v regione Sibiri i Dal'nego Vostoka [Epidemiology, clinical picture and prevention of borderline conditions in the region of Siberia and the Far East]. Nevropatologiya i psihiatriya. 1991;91(12):7–11. (In Russ.) 46. Kornetov AN. Depressivnye rasstrojstva vne psihiatricheskoj seti: rasprostranennost', kliniko-dinamicheskie i psihologicheskie zakonomernosti, farmako- i psihoterapiya [PhD thesis]. [Tomsk (Russia)]: Nauch.-issled. in-t psih. zdorov'ya Tom. nauch. centra SO RAMN]; 2010. 50 p. (In Russ.) 47. Depressiya. Vsemirnaya Organizaciya Zdravoohraneniya. Informacionnyj byulleten'. 2018. URL: https://www.who.int/ru/news-room/fact-sheets/detail/depression (accessed on: 31.03.23). 48. Kornetov AN. Ontogeneticheskie aspekty depressivnyh rasstrojstv [Ontogenetic aspects of depressive disorders]. Zh Nevrol Psikhiatr Im SS Korsakova. 2003;103(8):80–5. (In Russ.) 49. Avedisova AS, Zakharova KV, Mironova NV, Anosov JuA. [Features of age-related pathomorphosis of non-psychotic depressive disorders]. Zh Nevrol Psikhiatr Im SS Korsakova. 2013;113(11 2):7–13. (In Russ.) 50. Ivanets NN, Tiuvina NA, Voronina EO, Balabanova VV. [Comparative evaluation of depressive disorders in women and men]. Zh Nevrol Psikhiatr Im SS Korsakova. 2018;118(11):15–9. (In Russ.) DOI: https://doi.org/10.17116/jnevro201811811115 51. Lucht М, Schaub RT, Meyer C, et al. Gender differences in unipo lar depression: a general population survey of adults between age 18 to 64 of German nationality. J Affect Disord. 2003;77(3):203–11. DOI: https://doi.org/10.1016/s0165-0327(02)00121-0 52. Marcus SM, Kerber KB, Rush AJ, et al. Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. Compr Psychiatry. 2008;49(3):238–46. DOI: https://doi.org/10.1016/j.comppsych.2007.06.012 53. Maske UE, Buttery AK, Beesdo-Baum K, et al. Prevalence and correlates of DSM-IV-TR major depressive disorder, self reported diagnosed depression and current depressive symptom samongadults in Germany. J Affect Disord. 2016;190:167–77. DOI: https://doi.org/10.1016/j.jad.2015.10.006 54. Nazyrov RK. Otnoshenie k zdorov'yu i lecheniyu, intra- i interpersonal'naya konfliktnost' i koping povedenie u bol'nyh nevrozami [Attitude to health and treatment, intra- and interpersonal conflict and coping behavior in patients with neuroses]. Obozrenie psihiatrii i medicinskoj psihologii im. VM Bekhtereva. 1993;(4):20. (In Russ.) 55. Leinsalu M, Reile R, Stickley A. Economic fluctuations and long-term trends in depression: a repeated cross-sectional study in Estonia 2004–2016. J Epidemiol Community Health. 2019;73(11):1026–32. DOI: https://doi.org/10.1136/jech-2018-211939 56. Aluoja A, Leinsalu M, Shlik J, et al. Symptoms of depression in the Estonian population: prevalence, sociodemographic correlates and social adjustment J Affect Disord. 2004;78(1):27–35. DOI: https://doi.org/10.1016/s0165-0327(02)00179-9 57. Vasserman LI, Trifonova EA. Social'no-psihologicheskie faktory v formirovanii sfery zdorov'ya i lichnosti [Socio-psychological factors in the formation of health and personality]. Obozrenie psihiatr i med psihol im. VM Bekhtereva. 2012;(3):3–8. (In Russ.) 58. Chang CK, Hayes RD, Perera G, et al. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS One. 2011;6(5):e19590. DOI: https://doi.org/10.1371/journal.pone.0019590 59. WHO Guide to Mental and Neurological Health in Primary Care: A guide to mental and neurological ill health in adults, adolescents and children. R Jenkins, C Warlow, B Lewis, et al., editors. 2nd ed. Geneva: World Health Organization; 2004. 322 р. 60. Kostyuk GP, Masyakin AV, Burygina LA, Reverchuk IV. [The problem of diagnosis and treatment of depression by primary care physicians]. Zh Nevrol Psikhiatr Im SS Korsakova. 2019;119(1 2):55–61. (In Russ.) DOI: https://doi.org/10.17116/jnevro20191191255 61. Moitra M, Santomauro D, Collins PY, et al. The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: a systematic review and Bayesian meta-regression analysis. PLoS Med. 2022;19(2):e003901. DOI: https://doi.org/10.1371/journal.pmed.1003901 62. Kostyuk GP. [Actual problems of practical psychiatry: will the new Order of medical care for mental disorders and behavioral disorders solve them?]. Nacional'noe zdravoohranenie [National Health Care (Russia)]. 2023;4(1):48–54. (In Russ.) 63. Zinchuk MS, Guekht AB, Guliaeva NV, et al. [Biological basis of suicidal behavior]. Zh Nevrol Psikhiatr Im SS Korsakova. 2016;116(8):94–101. (In Russ.) DOI: https://doi.org/10.17116/jnevro20161168194-101 64. Lépine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat. 2011;7(Suppl 1):3–7. DOI: https://doi.org/10.2147/NDT.S19617 65. Boyd A, Van de Velde S, Vilagut G, et al. EU-WMH Investigators. Gender differences in mental disorders and suicidality in Europe: results from a large cross-sectional population-based study. J Affect Disord. 2015;173:245–54. DOI: https://doi.org/10.1016/j.jad.2014.11.002 66. Preventing Suicide: a global imperative. World Health Organization. International government publication. Geneva: World Health Organization; 2014. 92 р. 67. Bannikov GS, Eminova VS. [Prevention programs of suicidal behavior in adolescents]. Voprosy ohrany psihicheskogo zdorov'ja [Issues of Mental Health Prevention]. 2022;1(2):29–36. (In Russ.) 68. Nosova ES, Spasennikov BA, Aleksandrova OYu. Epidemiologiya samoubijstv v mire i faktory riska suicidal'nogo povedeniya [Epidemiology of suicide in the world and risk factors for suicidal behavior]. Byulleten' Nacional'nogo nauchno-issledovatel'skogo instituta obshchestvennogo zdorov'ya im. NA Semashko. 2021;(4):4–17. (In Russ.)



DOI: http://dx.doi.org/10.34757/1560-957X.2023.27.6.009

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM